Clinicopathological characteristics and follow-up outcomes of patients with oral potentially malignant disorders: A 7-year observational cohort study Authors: Sahel Azad, Sajad Torki, Azra Mohiti, Arghavan Etebarian Published: 2026 ABSTRACT AbstractOral potentially malignant disorders (OPMDs) comprise a group of oral mucosal abnormalities associated with an increased risk of malignant transformation. Early diagnosis, appropriate management, and long-term follow-up are essential to reduce the likelihood of cancer progression. This study aimed to evaluate the clinical and histopathological characteristics of OPMDs, their dysplastic changes, and clinical outcomes of patients referred to Alborz dental school between 2019 and 2025.This combined retrospective and prospective cohort study included 50 patients diagnosed with OPMDs. Data were collected using a standardized clinician-completed checklist, along with comprehensive clinical examinations and histopathological assessments. Recorded variables included demographic characteristics, type and location of lesions, and associated risk factors. The study population consisted of 64% females, with the majority of patients aged between 40 and 60 years. Plaque-type oral lichen planus and non-homogeneous leukoplakia were the most frequently diagnosed lesions. The buccal mucosa and tongue were the most commonly involved sites. Burning sensation was reported by 52% of patients. Histopathological examination revealed lichenoid mucositis in 86% of patients, with mild epithelial dysplasia observed in 7%. In contrast, dysplastic changes were identified in 57% of patients with leukoplakia. Therapeutic interventions included topical corticosteroids and intralesional corticosteroid injections. At follow-up, 80% of patients exhibited persistent lesions with plaque-type morphology and white lesions being most common; however, a subset of patients reported reduction in pain and burning sensation. Early diagnosis and structured long-term follow-up are essential for appropriate risk assessment and early detection of potential malignant progression Keywords: Precancerous Conditions; Leukoplakia, Oral; Oral Lichen Planus; Epithelial Dysplasia; Follow-Up StudiesSubject terms: Cancer, Diseases, Health care, Medical research, Oncology Introduction Oral potentially malignant disorders (OPMDs) are defined as oral mucosal abnormalities that are statistically associated with an increased risk of developing oral cancer.1 These disorders encompass a spectrum of diseases with diverse clinical appearances, histological subtypes, and risk factors or etiologies. Common OPMDs include oral Leukoplakia (OLK), Erythroplakia, Erythroleukoplakia, oral lichen planus (OLP), and oral submucous fibrosis (OSF).2,3 Among these, leukoplakia is the most prevalent, defined as a predominantly white plaque of questionable risk, excluding other known diseases or disorders that do not carry an increased risk for cancer.2. OLP, with a global prevalence of 1.01%, is a chronic inflammatory disorder of unclear etiology.4,5 It presents with polymorphous clinical features, ranging from intermittent symptomatic flares to persistent disease activity, which can significantly impact patients’ quality of life.6,7 Due to its potential to progress to oral squamous cell carcinoma (OSCC) in approximately 1% of cases, OLP is also classified as an OPMD.8 OLK, with a global prevalence of 3.41%, presents with different clinical features like homogeneous and non-homogeneous forms and may cause burning sensation and discomfort in symptomatic patients, which affects their quality of life significantly, but it is often asymptomatic.3,9,10 Since the malignant transformation rate is estimated to be approximately 7%, OLK is also classified as an OPMD.11. The malignant transformation rate of OPMDs varies widely across studies, ranging from 0.13% to 36.3%.1 This variability underscores the importance of identifying and analyzing factors that influence the progression of OPMDs, such as patient demographics, lesion type, location, and lifestyle risk factors like tobacco and alcohol use.4,12 By investigating these factors, this study provides an overview of the clinicopathological characteristics, dysplastic changes and follow-up outcomes of patients with oral potentially malignant disorders attending Alborz dental school from 2019 to 2025. The findings highlight the importance of careful clinical evaluation and histopathological assessment, as well as regular follow-up in the management of these patients. Materials and methods Patients’ identification This study employed a retrospective and prospective cohort design to investigate OPMDs among patients diagnosed at Alborz dental school during 7 years. The study period spanned from 2019 to 2025, with project initiation in 2023. In the retrospective phase (2019–2022), pathology archives were reviewed to identify cases of oral potentially malignant disorders (OPMDs) based on predefined inclusion criteria. These patients were subsequently contacted and invited for a follow-up visit. For those who agreed to participate, written informed consent was obtained, and additional clinical information was collected using a standardized checklist during the follow-up examination. In the prospective phase (2023–2025), all newly diagnosed OPMD patients were consecutively enrolled. For these patients, the checklist was completed after histopathological confirmation, and follow-up was conducted in accordance with the study protocol. Overall, the study included a 4-year retrospective component and a 3-year prospective component. In prospective phase, patients with suspected OPMDs were identified through routine clinical examinations performed across all departments of the dental school. Whenever a clinician encountered a lesion with features suggestive of OPMD, the patient was referred to the Oral Medicine Department for further evaluation. An oral medicine specialist then performed a comprehensive clinical examination to determine whether the lesion clinically met the criteria for an OPMD. Patients whose lesions were clinically ruled out were excluded from the OPMD registry. For cases requiring additional diagnostic confirmation, a biopsy was performed in the Oral and maxillofacial Medicine, Periodontics, or Oral Surgery departments, and the specimen—accompanied by the clinical report—was submitted to the Oral Pathology Department. Biopsy sites were selected based on clinical examination, with preference given to areas exhibiting the most suspicious features, such as erythema, induration, or surface changes. No adjunctive chairside diagnostic tools (e.g., toluidine blue staining) were used to guide biopsy site selection. Based on the histopathologic findings, patients were categorized as having no potentially malignant changes, histopathologic evidence of mild-to-severe dysplasia, or malignancy. Clinical diagnosis and follow-up assessments were performed by a single experienced clinician, while histopathological evaluations were conducted by a single oral pathologist. During follow-up, lesions were assessed through clinical examination, with documentation of changes in size, appearance, and persistence or resolution. However, no standardized quantitative measurement tools or calibrated methods were used, and lesion changes were recorded descriptively. All cases of OPMD were confirmed by histopathologic examination. In selected cases, where biopsy was not feasible or was declined by the patient, diagnosis was based on characteristic clinical features and recorded accordingly. For every registered patient, essential data were recorded in standardized clinician-completed checklist, including demographics, medical and medication history, habits and risk factors, clinical features, clinical diagnosis, histopathologic features, and the medical or non-medical treatment plan. This structured identification and referral system ensured consistent screening, diagnosis, and registry of all OPMD cases within the dental school. Although a formal staging system such as the OLEP/LSCP classification for leukoplakia cases was not applied, key parameters including lesion size, anatomical site, and histopathological grading of epithelial dysplasia were recorded for all cases.13 Patients with other pathological lesions, non-responsive to follow-up phone calls, or unwilling to participate in the study were excluded from the study. Follow-up protocol for OPMD patients The follow-up of patients diagnosed with OPMDs was performed according to Awadallah et al. study.14 All clinically suspected cases of OPMDs were evaluated by an oral medicine specialist and enrolled in the OPMD registry after obtaining written informed consent. Follow-up visits were conducted according to the study protocol, and clinical findings recorded during these visits were documented as follow-up data. Baseline data were defined as information collected at the time of initial diagnosis prior to enrollment including demographics, medical history, risk factors, clinical characteristics, and histopathologic findings at the time of diagnosis. Follow-up intervals were determined based on clinical and histologic status. Patients without dysplasia or with mild–moderate dysplasia were recalled every six months during the first year and annually thereafter, while those with severe dysplasia or carcinoma in situ were followed every three months for the first two years and every six months subsequently. At each follow-up visit, changes in risk factors, lesion dimensions, and morphology were documented, and the treatment plan was updated accordingly. Management decisions were guided by lesion risk category, with high-risk anatomical sites receiving more aggressive interventions, including excisional surgery with appropriate margins. Statistical analysis Given the registry-based design of the study, all eligible patients diagnosed with OPMDs during the study period were included, and no formal sample size calculation was performed. Data were entered into SPSS software (version 26), quantitative variables were described using mean and standard deviation, while qualitative variables were summarized as frequencies and percentages and presented in tables and graphs. Comparisons of categorical variables were performed using the Chi-square test. Data were analyzed at both the patient level and lesion level. Lesion-specific variables (site, color, morphology) were recorded and analyzed per lesion, whereas demographic and clinical variables (age, gender, medical history, medication use, and final diagnosis) were analyzed per patient. As some patients presented with multiple lesions, lesion-level analyses were considered descriptive and no adjustment for intra-patient clustering was performed. This study was designed as a descriptive cohort; no inferential statistical analyses were performed. Ethical considerations Patient information was entered into the Oral Cavity Premalignant Disorders Registration and Monitoring System after obtaining written informed consent. This study adhered to ethical guidelines and did not interfere with the standard diagnostic or treatment processes for the patients. Participation was entirely voluntary, and all patients provided explicit permission for their data to be used. The study protocol was reviewed and approved by the Research Ethics Committee of Alborz University of Medical Sciences (Approval ID: IR.ABZUMS.REC.1402.043). Results This study was conducted on 50 patients with OPMDs between 2019 and 2025 to assess their clinical and histopathological features. Demographic and clinical characteristics of patients with OPMD The study population consisted predominantly of females (64%). A statistically significant gender distribution was observed (P = 0.048). Most patients were between 40 and 60 years of age (P = 0.004), while 30% were younger than 40 years and 16% were older than 60 years. Among the patients, 50% were high school graduates, 28% had college degrees, and others had less than a high school education. Results showed that 22 patients were housewives,19 of them were employed, and the remaining had other jobs. A + was the most common blood type, accounting for 26% of the patients, 22% were O+, and 16% were B+. Additionally, 30% did not know their blood type, and the remaining had other types. (Table 1) Table 1Patients’ demographics and characteristics.Patients’ demographicn (%)GenderFemale32 (64%)Male18 (36%)Age(yrs.)Under 4015 (30%)40–6027 (54%)Over 608 (16%)EducationCollege degree14 (28%)High school education25 (50%)Less than a high school education11 (22%)OccupationHousewives22 (44%)Employed19 (38%)Have income without working6 (12%)Others3 (6%)Blood typeA+13 (26%)O+11 (22%)B+8 (16%)O-2 (4%)A-1 (2%)B-0 (0%)Lack of information15 (30%) Patients’ demographics and characteristics. Results showed that half of the patients did not have any systemic diseases, and 57.1% of them were taking medications, while 42.9% did not take any drugs. Hypothyroidism (28.1%) and Diabetes mellitus type 2 (18.7%) were the most common systemic diseases among patients. The most common mediations taken by patients were cardiovascular drugs such as Aspirin and Metoral (17.2%), followed by antidepressants such as Asentra and Citalopram (13.7%), and antihypertensive drugs such as Losartan and Propranolol (13.7%). A familial history of cancer was reported in 15 patients, whereas 70% reported no family history of cancer. According to Table 2, 30% of patients reported a history of cigarette smoking, and one patient had a history of drug abuse. Hookah use was reported by 14% of patients, and alcohol consumption was observed in six patients. Table 2Distribution of alcohol consumption and smoking habits among patients with OPMDs.HabitsResponsesn (%)Alcohol consumptionNo44 (88%)Yes5 (10%)Former user1 (2%)Cigarette smokingNo35 (70%)Yes15 (30%)Smokeless tobaccoNo50 (100%)Yes0 (0%)Drug abuseNo49 (98%)Yes1 (2%)Hookah useNo43 (86%)Yes6 (12%)Former user1 (2%) Distribution of alcohol consumption and smoking habits among patients with OPMDs. Clinical presentation of the lesions During the 7-year study duration, a total of 108 lesions were identified in 50 patients. Multiple lesions were seen in 76% of patients, while the remaining 24% had single lesions. Lesion characteristics (site, color, morphology) were analyzed at the lesion level, while demographic and clinical data were analyzed at the patient level. The buccal mucosa was the most common site, accounting for 58.4% of lesions, followed by the lateral border of the tongue with 17.6% and the maxillary buccal gingiva with 6.6%. The maxillary buccal vestibule was the least affected site, representing 0.9% of the lesions. Figure 1 shows the clinical view of six patients with oral potentially malignant disorders. Plaque-type lesions were the most common clinical morphology among premalignant lesions, accounting for 55.4% of cases, followed by erosive lesions (18.2%). Ulceration was the least frequent presentation, observed in only five lesions. Regarding surface characteristics, a papular surface was the most prevalent (72.2%), followed by a flat surface (20.4%), while verrucous surfaces were rare, being identified in only three lesions. Most lesions (95.3%) had a greatest diameter ranging from 1 to 5 cm, whereas lesions exceeding 5 cm accounted for the remaining cases. In terms of color, two lesions were purely red, 37 were white, and 69 exhibited a mixed red and white appearance. Clinical view of patients with oral potentially malignant lesions: A. Red and white lesion with final diagnosis of Lichen planus on buccal mucosa. B. non-homogenous white plaque on buccal mucosa (C) Red and white lesion with clinical diagnosis of leukoplakia on the lateral border of the tongue. (D) Leukoplakia on the ventral area of the tongue. (E) Desquamative gingivitis in a patient with lichen planus. (F) Lichen planus with post-inflammatory pigmentation on buccal mucosa. Burning sensation was the most common clinical symptom among patients, reported in 52% of cases. In contrast, 34% of patients reported no symptoms. Pain, the third most common symptom, was observed in 14 patients. Among the 50 patients included in this study, 20.5% were unaware of their lesions, which were asymptomatic and detected during routine examinations. In contrast, 29.6% reported awareness of the lesions for 6–12 months, and an additional 29.6% reported awareness for more than 12 months. Clinicopathologic findings of the lesions Incisional biopsy was performed in 46 patients, while excisional biopsy was carried out only in two patients. OLP was diagnosed based on the modified WHO criteria. In two cases, diagnosis was made clinically due to typical bilateral reticular lesions and classical presentation; histopathological confirmation was not performed in these cases due to patients’ refusal to undergo biopsy. Hyper-parakeratinized epithelium (clinical diagnosis: OLK) was observed in 7 patients and 86% of patients (n = 43) were diagnosed as lichenoid mucositis (clinical diagnosis: 39 OLP and 4 oral lichenoid lesions). Figure 2 denotes the histopathologic view of biopsied lesions. H & E-stained sections (A-F) of oral squamous epithelium with different architectural and cytological dysplastic changes. (A) Hyperkeratotic squamous epithelium with disorganized basal cells and nuclear hyperchromasia (×100). (B) Basal cell nesting /clustering with hyperchromasia and increased number of nucleoli (×200). (C) Loss of polarity of basal cells with premature and single cell keratinization (×200). (D) Generalized premature keratinization with reduced keratinocytes cohesion (×200). (E) Lichenoid mucositis with drop-shaped rete processes and keratin pearl formation (×100). (F) Lichenoid mucositis with single cell keratinization showing mild dysplasia (×100). Dysplastic changes in histopathology of OPMDs lesions were observed in14% of patients. Among 43 patients with lichenoid mucositis, 3 (7.0%) showed mild dysplasia. In addition, 4 out of 7 cases (57.1%) of hyperplastic parakeratotic epithelium demonstrated epithelial dysplasia. The clinicopathologic characteristics of these dysplastic cases are summarized in Table 3. 3 Among three patients with mild dysplastic lichenoid mucositis (clinical diagnosis: OLP), two were male, and two reported hookah use. With respect to age, two patients were younger than 40 years, while one was between 40 and 60 years of age. OLP lesions were predominantly located on the buccal mucosa and tongue. Case one presented with a mixed red-and-white lesion on the tongue mucosa exhibiting ulcerative morphology and a papular surface. Case two showed a mixed red-and-white buccal mucosal lesions with plaque-type morphology, Wickham striae, and a verrucous surface. In the third patient, a mixed red-and-white lesion on bilateral buccal mucosa demonstrated plaque-type morphology with a papular surface.(Table 3) Table 3Clinicopathologic characteristics of OPMD patients with dysplastic changes.CaseFinal DiagnosisDysplasia gradeAge (years)GenderBlood groupFamily history of cancerSmoking / Hookah/ alcoholconsumptionLesion location1Oral lichen planusMild46FemaleUnknownNot presentNoneTongue (solitary)2Oral lichen planusMild35MaleA+Not presentHookah useBilateral buccal mucosa3Oral lichen planusMild32MaleO+Not presentHookah useBilateral buccal mucosa4Oral leukoplakiaMild56FemaleUnknownNot presentNoneTongue5Oral leukoplakiaModerate52MaleO+Not presentNoneTongue6Oral leukoplakiaMild49MaleO+Not presentNoneBuccal mucosa7Oral leukoplakiaMild46MaleA+PresentCigarettesmokingBuccal mucosa Clinicopathologic characteristics of OPMD patients with dysplastic changes. Cigarette smoking Among four patients with dysplastic hyper-parakeratotic epithelium (clinical diagnosis: OLK), one case exhibited moderate dysplasia (case 5) and other cases showed mild dysplasia. All patients were between 40 and 60 years of age, and only one reported cigarette smoking (case 7). Leukoplakic lesions with dysplastic changes were equally distributed between the buccal mucosa and the tongue. Clinically, these lesions predominantly presented with plaque-type morphology and a papular surface. Three lesions were white in color, whereas one exhibited a mixed red-and-white appearance (Case 4). Treatment options Treatment modalities for the total 108 lesions identified in 50 patients included drug therapy for 55 lesions and intralesional corticosteroid injections for 43 lesions. Topical corticosteroids were the mainstay of therapy, with triamcinolone acetonide (0.1%) commonly prescribed as a mouthwash or topical application, typically administered 2–3 times daily for a duration of 2–8 weeks depending on lesion severity. In selected cases, topical betamethasone (0.05%) was used in a similar regimen. Intralesional triamcinolone injections were administered in persistent or symptomatic lesions at appropriate intervals based on clinical response. Additional management approaches comprised oral hygiene instructions and scaling (3.6%), surgical excision (3.6%), and laser therapy (1.9%). In most instances, drug therapy consisted of a combination of triamcinolone and an aluminum–magnesium hydroxide suspension, which functioned as a mucosal coating agent rather than a systemic antacid. Adjunctive therapies included nystatin antifungal mouthwash (particularly in plaque-type oral lichen planus cases to prevent secondary candidiasis), as well as dietary supplements such as zinc (typically 30–50 mg/day) and vitamin D (1000–2000 IU/day) administered for several weeks as supportive therapy. Patients follow up All patients included in the study attended at least one follow-up visit, conducted 3–6 months after the initial diagnosis, depending on lesion type and severity of the symptoms. The median follow up duration was 18 months (IQR: 12–36 months) and patients attended a median of approximately 3 follow-up visits (range: 1–5 visits). A follow- up process at 3–6 months was initiated for each patient based on the diagnosis of the lesion and plaque -like lesions were followed at least for 6 months with follow up interval of 3 months. Other type of lesions was followed at 3-month time line after the end of a successful treatment. At follow-up, persistent lesions were observed in the majority of patients (80%). Consistent with baseline findings, the buccal mucosa (56%) and tongue (24%) remained the most frequently affected sites. A proportion of patients reported improvement in symptoms, particularly a reduction in pain (5%) and burning sensation (20%). In terms of clinical morphology, plaque-type lesions remained the predominant presentation, accounting for approximately 70% of cases, followed by erosive lesions identified in 10 patients. A change in lesion characteristics was observed over time, with several initially heterogeneous and mixed red-and-white lesions presenting as more homogeneous, predominantly white plaque-like lesions at follow-up. Regarding lesion color, white lesions were the most common (62%), whereas mixed red-and-white lesions accounted for 23% of cases. Most lesions detected during follow-up measured less than 5 cm. Additionally, two new lesions were identified during follow-up in two patients, one located on the buccal mucosa and the other on the tongue, both presenting as white plaques. In terms of management, medication therapy was prescribed in 50% of cases, followed by intralesional corticosteroid injections in 22.2%. Discussion OPMDs are defined as epithelial lesions in the oral cavity that carry a risk of malignant transformation.15 These lesions are identified clinically and examined histopathologically, and may or may not exhibit dysplasia. 16 Longitudinal studies have shown that areas of tissue with clinical alterations, initially identified as ‘precancerous’, may undergo malignant transformation during follow-up sessions.2 Diagnosis typically begins with a clinical examination, and lesions may appear as leukoplakia, erythroplakia, erythroleukoplakia followed by OLP and OSF. Once the diagnosis is confirmed, the patient’s risk factors are assessed to determine malignant transformation potential and guide appropriate treatment. 15 In addition, the accurate diagnosis of OLP and oral lichenoid lesions may require patient-specific information such as symptoms, medication history, systemic diseases and other relevant information submitted with the biopsy request. 17 This cohort study evaluated the clinical and histopathological features of OPMDs in patients at Alborz dental school between 2019 and 2025. Results showed that 76% of lesions were multiple, and burning sensation was the most common symptom. The most frequent lesion sites were the buccal mucosa and the lateral borders of the tongue. Histopathological analysis revealed that 86% of biopsied specimens were diagnosed as lichenoid mucositis. Most lesions appeared as red and white plaques with papular surface. Comparative studies reported similar findings regarding lesion morphology and location18–20 However, study conducted in Brazil found actinic cheilitis in the lower lip as the most common OPMD lesion18 with regional differences in lesion distribution and UV exposure.20 Reichart and colleagues found that the floor of the mouth, ventral and lateral borders of the tongue, and the soft palate were more susceptible to malignant changes, which aligns with the dysplastic changes observed in tongue lesions in this study. The results show significantly higher prevalence of OPMDs in women and in individuals between 40 and 60 years of age, align with recent results of Wang cohort study.22 Speight and colleagues noted that the most OPMD cases were diagnosed in middle-aged or elderly patients, predominantly males.23 Ethnicity and associated cultural risk factors might influence the type and pattern of OPMDs in specific populations, consistent with findings of other relevant studies, though differences in gender distribution and correlations with education or occupation were noted, possibly due to variations in study populations and the fact that women seek treatment more often24–26. Hypothyroidism and diabetes were the most common systemic diseases among patients with OPMDs, while other studies reported a high prevalence of diabetes in these patients.27–29 The high prevalence of hypothyroidism in our cohort may be noteworthy, as previous studies have suggested an association between thyroid disorders and oral lichen planus/lichenoid lesions.30,31 In addition, oral lichenoid reactions are often drug-induced hypersensitivity responses, and patients with hypothyroidism frequently receive long-term medications, which may act as potential triggers.32,33 However, causality cannot be inferred from the present findings. Furthermore, 38% of patients had a history of smoking or drug abuse. Areca nut consumption was not assessed in this study due to its low prevalence in this region. However, studies in Taiwan found both areca nut and smoking as significant risk factors.34 Socioeconomic status and alcohol consumption have also been reported as contributing factors in other study reports.35 Blood group distribution was evaluated as an exploratory variable in this study. Among patients with available data, A + was the most common blood group (26%). Previous studies have suggested a possible association between ABO blood groups and susceptibility to oral potentially malignant disorders and oral cancer, with some reports indicating a higher prevalence in individuals with blood group A.36,37 However, in the present study, a considerable proportion of missing data (30%) limits the ability to draw definitive conclusions. Therefore, this finding should be interpreted with caution. Management of OPMDs is mostly based on risk factors elimination and careful monitoring for high-risk cases based on incisional biopsy results, while excisional biopsy is the preferred management approach for high-risk cases (moderate or severe dysplasia in histopathology or lesions in high-risk sites such as the lateral border of tongue and floor of the mouth). 38 The treatment approaches used in this study are consistent with current evidence-based recommendations, which identify topical corticosteroids as the first-line therapy for symptomatic oral lichen planus and related OPMDs. Multiple systematic reviews and clinical trials have demonstrated their efficacy in reducing inflammation and alleviating symptoms, with agents such as triamcinolone, betamethasone, and dexamethasone commonly used in clinical practice.39–41 Adjunctive therapies, including zinc and vitamin D supplementation, have been investigated for their potential immunomodulatory and anti-inflammatory effects, although their additional benefit remains variable across studies.42 Align with our results, Yardimci and colleagues reported corticosteroid therapy as the most common treatment option, while photodynamic therapy could be considered for extensive lesions. In moderate and severe epithelial disorders, surgical excision must be advised. 38 Our results suggest that OPMD lesions exhibiting papular or verrucous surface morphologies, were more likely to demonstrate dysplastic changes on histopathology. This observation aligns with existing clinical evidence indicating that non-homogeneous surface features in OPMDs are associated with an elevated risk of dysplasia and malignant progression.43 Specifically, non-homogeneous leukoplakias with verrucous, papillary, or corrugated surfaces have been reported to possess a significantly higher probability of dysplastic or malignant transformation compared to homogenous, smooth lesions, with studies suggesting several-fold increased risk in such surface-altered lesions.11 Although most large cohort studies focus on transformation rates by lesion subtype rather than fine-grained surface descriptors, these clinicopathological correlations reinforce the notion that surface morphology is a useful clinical cue for stratifying dysplasia risk and may warrant closer surveillance or more aggressive biopsy sampling in lesions with papular or verrucous features. In this study, the distinction between oral lichen planus and oral lichenoid lesions was made according to modified WHO clinical diagnostic criteria.44 Patients with clinically bilateral and relatively symmetrical lesions in the absence of identifiable etiologic factor were diagnosed as OLP. In contrast, lesions were classified as oral lichenoid lesions when clinical features were unilateral or asymmetrical and/or when a potential triggering factor was identified, including direct contact with dental restorative materials, history of drug intake, or association with systemic conditions.45,46 In this study, three out of 43 patients with lichenoid mucositis showed dysplastic changes, two had bilateral lesions in the buccal mucosa, and one had a solitary lesion on tongue with no other etiologic factors (confirmed clinical diagnosis : OLP). Some authors believed that distinguishing OLP from oral lichenoid lesions is essential due to the higher malignant transformation rate associated with oral lichenoid lesions23,17 and reported the malignant transformation rates of 1.09% and 0.9% for OLP, in comparison to 3.2% and 2.5% for oral lichenoid lesions47,48 This is in contrast with our results that the dysplasia happened in patients with oral lichen planus and not in lichenoid lesions. Accurate diagnosis directly influences patient management, elimination of etiologic factors, and long-term follow-up strategies. Lichenoid mucositis is a chronic immune-mediated inflammatory condition with a relapsing–remitting course, in which periods of exacerbation and remission are common. Therefore, persistence of clinical lesions at follow-up does not necessarily indicate treatment failure and should be interpreted alongside symptomatic changes.49. During the present study, no progression to OSCC was observed in patients with OPMDs. This finding should be interpreted with caution, as the duration of follow-up and the predominance of lower-risk lesions (lichenoid mucositis) may have limited the likelihood of observing malignant transformation within the study period. Furthermore, epithelial dysplasia may be absent in initial biopsies of OLP but can develop over time; therefore, a negative biopsy does not exclude malignant potential, and such cases should be enrolled in a structured long-term follow-up protocol.16,50 Malignant transformation has been reported in a proportion of leukoplakia cases that were not biopsied with the rates around 3.1–4.6%51, underscoring the importance of routine follow-up visits and histopathological evaluation of OLKs, particularly those exhibiting dysplastic changes, to reduce the risk of malignant transformation.52 Although the main components of the OLEP/LSCP classification were evaluated, a formal staging system was not applied, which may limit direct comparison with studies using standardized staging approaches.13. The findings of this study should be interpreted with caution due to the relatively small sample size, limited number of dysplastic lesions, and short follow-up duration. The descriptive nature of the study and limited statistical power restrict definitive conclusions regarding potential associations and malignant transformation risk. As this was a single-center registry-based study including all eligible cases during a defined study period, no formal sample size calculation was performed. Consequently, the generalizability of the findings may be limited, particularly for detecting less frequent outcomes such as malignant transformation. Furthermore, lesion assessment during follow-up was primarily based on clinical observation without standardized quantitative measurements, which may have introduced subjectivity and limited reproducibility. The retrospective phase of the study also posed challenges related to data completeness, patient follow-up, and in-person evaluations, resulting in incomplete access to some patient information and reduction in the final study population. Therefore, the findings should be considered exploratory, and larger multicenter studies with longer follow-up periods are recommended to validate the present results. There are still controversial results denoting the prognosis of OSCC patients arising from OPMDs, therefore further studies are warranted to examine the patients’ survival and outcomes. We recommend that future studies compare patients with OPMDs with healthy controls to enhance the understanding of risk factors. Also, a longer and more detailed follow-up period is advised to monitor the risk of OSCC progression and evaluate the effectiveness of treatments. Given the necessity and importance of consistent monitoring, a structured follow-up protocol, early detection and early intervention if needed should be maintained for affected patients. Conclusion This seven-year cohort study of 50 patients with OPMDs at Alborz Dental School highlights the predominance of plaque-type oral lichen planus and leukoplakia, with dysplastic changes observed in 14% of cases on histopathological examination. Identified patient characteristics included middle age, female predominance, tobacco use, and systemic conditions such as diabetes and hypothyroidism. Despite persistence of clinical lesions in most patients at follow-up, improvement in symptoms, particularly pain and burning sensation, was observed in a subset of cases. This finding reflects the chronic and fluctuating nature of these conditions and suggests that clinical persistence alone may not fully represent treatment response. Overall, this study provides an overview of the clinicopathological characteristics and follow-up outcomes of OPMDs, emphasizing the importance of integrating clinical evaluation with histopathological assessment and maintaining regular follow-up in patient management. However, the findings should be interpreted with caution due to the limited sample size and variability in follow-up, and further large-scale studies are warranted to validate these observations. Acknowledgements The authors wish to appreciate the Clinical Research Development Unit of Dental School, Alborz University of Medical Sciences for technical assistance, and all patients who kindly agreed to take part in this study. Author contributions Sahel Azad: Conceptualization, Investigation, Writing-Original draft preparationSajjad Torki: Methodology, Writing- Review & editingAzra Mohiti: Supervision, Investigation, Writing- Review & editingArghavan Etebarian: Conceptualization, Investigation, Project administration, Supervision, Writing- Review & editing. Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Data availability The data supporting the findings of this study are available from the corresponding author upon reasonable request, subject to institutional and ethical regulations. Declarations Competing interests The authors declare no competing interests. Ethics approval This study was approved by the Ethics Committee of Alborz University of Medical Sciences. (Approval ID: IR.ABZUMS.REC.1402.043). Consent for publication All clinical and histopathological images are fully anonymized beyond recognition. The Ethics Committee approved the use of these images for publication, and no identifying patient information is disclosed. Consent to participate Informed consent was obtained from all individual participants included in the study. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data supporting the findings of this study are available from the corresponding author upon reasonable request, subject to institutional and ethical regulations.